AI assistant
Sending…
GENTEX CORP — Director's Dealing 2015
Aug 21, 2015
30893_dirs_2015-08-21_f9fb3553-85b5-431e-8530-bc4aa7d6e975.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2015-08-20
Reporting Person: Ryan Scott P (General Counsel)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6112 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $14.73 | 2015-12-28 | Common Stock (3000) | Direct | |
| Employee Stock Option (Right to Buy) | $14.96 | 2016-12-29 | Common Stock (4726) | Direct | |
| Employee Stock Option (Right to Buy) | $9.375 | 2017-12-27 | Common Stock (4920) | Direct | |
| Employee Stock Option (Right to Buy) | $16.415 | 2018-12-30 | Common Stock (7220) | Direct | |
| Employee Stock Option (Right to Buy) | $18.31 | 2019-12-30 | Common Stock (8320) | Direct |
Footnotes
F1: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.
F2: Options granted under the Gentex Corporation Employee Stock Option Plan which is a Rule 16B plan.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19